Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05669976 · ClinicalTrials.gov registry record · NA
Suicide Prevention for Sexual and Gender Minority Youth (Randomized Controlled Trial)
A NA study of Suicide, sponsored by San Diego State University.
- Recruiting
- Registry status
- NA
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT05669976: Recruiting NA study of Suicide, sponsored by San Diego State University.
NCT05669976 is a NA study of Suicide that is actively recruiting participants, run by San Diego State University. The registered enrollment target is 170 participants, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05669976, a NA study of Suicide, is actively recruiting participants, sponsored by San Diego State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this study is to evaluate a newly-developed suicide prevention program for sexual and gender minority youth and emerging adults. After development of the intervention program, a randomized controlled trial will be conducted to test its preliminary efficacy in lowering the risk for suicide attempts.
Primary Outcome
Assess presence or absence of suicide attempts (i.e., actual, interrupted, or aborted) over the twelve-month follow-up period
Conditions Studied
Interventions
- BEHAVIORAL Safety Planning Intervention
- BEHAVIORAL Safety Planning Intervention with Navigation Services
Study Locations (1)
California
- San Diego State University - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2023-04-10 |
| Est. Completion | 2027-04-15 |
| Phase | NA |
What NCT05669976 shows while recruiting
NCT05669976 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 6,988-participant average among 92 other Suicide trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Safety Planning Intervention is the first listed.
NCT05669976 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05669976 about?
NCT05669976 is a clinical study titled "Suicide Prevention for Sexual and Gender Minority Youth (Randomized Controlled Trial)". The overarching goal of this study is to evaluate a newly-developed suicide prevention program for sexual and gender minority youth and emerging adults. After development of the intervention program, a randomized controlled trial will be conducted to test its preliminary efficacy in lowering the ris...
What is the current status of trial NCT05669976?
This trial is currently recruiting. It is a NA study. The enrollment target is 170 participants. The study started on 2023-04-10. Estimated completion is 2027-04-15.
What conditions does trial NCT05669976 study?
This clinical trial studies the following conditions: Suicide.
What interventions are being tested in trial NCT05669976?
The interventions under investigation include: Safety Planning Intervention (BEHAVIORAL), Safety Planning Intervention with Navigation Services (BEHAVIORAL).
Who is sponsoring clinical trial NCT05669976?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05669976 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05669976's enrollment target sits among peer trials
170 37th of 92 higher than 56 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI